Pharmaceuticals in Asia-Pacific
SummaryPharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Asia-Pacific pharmaceuticals market had total revenues of $324.8m in 2018, representing a compound annual growth rate (CAGR) of 6.5% between 2014 and 2018.
- The performance of the market is forecast to accelerate, with an anticipated CAGR of 9% for the five-year period 2018-2023, which is expected to drive the market to a value of $500.6m by the end of 2023.
- South Korea and Japan contrast the performance of the region as a whole. Low rates of growth show those markets are mature and pressure is exerted on reducing costs within their healthcare systems.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Asia-Pacific
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pharmaceuticals market with five year forecasts
Reasons to buy
- What was the size of the Asia-Pacific pharmaceuticals market by value in 2018?
- What will be the size of the Asia-Pacific pharmaceuticals market in 2023?
- What factors are affecting the strength of competition in the Asia-Pacific pharmaceuticals market?
- How has the market performed over the last five years?
- How large is Asia-Pacific’s pharmaceuticals market in relation to its regional counterparts?
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.